Health Awareness
New report cites 23 child deaths could have been prevented through appropriate vaccination
On Thursday, January 11, 2018, a major report entitled, ‘Child Deaths from Vaccine Preventable Infectious Diseases‘ between 2005 and 2014 was published in the Journal of Paediatrics and Child Health. Report authors – National Centre for Immunisation Research and Surveillance (NCIRS), the Sydney Children’s Hospital Network and University of Sydney researchers – cited 54 child…
Read MoreSouth Africa’s leading independent health communications agency joins GLOBALHealthPR
World’s largest independent healthcare communications network strengthens market-leading offering across Asia Pacific, North America, South America, Europe & Africa GLOBALHealthPR®, the largest independent health and science communications agency partnership worldwide, represented exclusively by VIVA! Communications in Australia, today welcomed Johannesburg-based F/NE to its rapidly expanding global network. Founded more than 18 years ago, F/NE has…
Read MoreNational Education Initiative launched to support youth mental health
Leading Australian mental health organisations have come together today to announce the launch of a new National Education Initiative transforming the country’s approach to youth care. From August 2018, beyondblue, headspace, and Early Childhood Australia will attempt to provide an end-to-end mental health framework in schools. The National Education Initiative has attracted AUD$45m in funding…
Read MoreDifference between physiotherapy and chiropractic
The majority of people will experience some kind of neck pain, back pain or other musculoskeletal injury at some point throughout their lives. Whether this be a sporting injury, as a result of a car accident or simply from general wear and tear of the joints and muscles in our body, most people who seek…
Read MoreAustralian developed, first-in-class rheumatoid arthritis medication secures green-light for human trials in Brisbane
Australia’s first in-human study of a first-in-class rheumatoid arthritis immunotherapy treatment developed by University of Queensland researchers was launched on November 14, 2017. The Phase 1, double-blind, placebo-controlled study currently underway at Brisbane’s Princess Alexandra Hospital, will consider both single-ascending dose, and multi-dose protocols to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous (under…
Read More